Position:
Executive Committee at Biomarkers Consortium, Head, Global Regulatory Affairs at AstraZeneca, VP and Head, Global Regulatory Affairs at AstraZeneca, Board of Directors at Orexigen Therapeutics, Advisory Board Member at Excellentia Global Partners, Charter Member, Advisory Board at Regulatory Harmonization Institute, Charter Member, Advisory Board at Regulatory Harmonization Institute, Associate Editor at Clinical Pharmacology & Therapeutics
Location:
Greater Philadelphia Area
Work:
Biomarkers Consortium
since Mar 2013
-
Executive Committee
AstraZeneca
since Jul 2010
-
Head, Global Regulatory Affairs
AstraZeneca
since Jul 2010
-
VP and Head, Global Regulatory Affairs
Orexigen Therapeutics
since Mar 2010
-
Board of Directors
Excellentia Global Partners
since Jan 2010
-
Advisory Board Member
Regulatory Harmonization Institute
since Jan 2010
-
Charter Member, Advisory Board
Clinical Pharmacology & Therapeutics
since Jan 2008
-
Associate Editor
Institue of Medicine
Jun 2010 - Sep 2011
-
Member, Committee on Scientific Standards for Studies on Modified Risk Tobacco Products
Generation Health
Jan 2010 - Sep 2010
-
Clinical Advisory Board
B&D Consulting
Jan 2010 - Jun 2010
-
Senior Advisor
Peter Honig Regulatory and Medical Advisors, LLC
Jan 2010 - May 2010
-
Pharmaceutical Consultant
Merck
Mar 2002 - Dec 2009
-
Merck Research Laboratories
FDA Center for Drug Evaluation and Research
1990 - 2002
-
Medical Officer
Georgetown University
Jul 1989 - Oct 1990
-
Assistant Professor
Northwestern University
1982 - 1985
-
Housestaff
Education:
Uniformed Services University of the Health Sciences - F Edward Hebert SOM 1990 - 1993
Fellowship, Clinical Pharmacology
Columbia University in the City of New York 1987 - 1989
MPH
Columbia University College of Physicians and Surgeons 1978 - 1982
Doctor of Medicine (MD)
Columbia University in the City of New York 1974 - 1978
BA, History